QI
VCYT icon

Qtron Investments’s Veracyte VCYT Stock Holding History

Qtron Investments’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-8,776
Closed -$250K – 277
2019
Q2 		$250K Hold
8,776
– – 0.16% 201
2019
Q1 		$220K Buy
+8,776
New +$168K 0.2% 176

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Qtron Investments's VCYT Position: Q3 2019 in Review

Qtron Investments sold out of Veracyte (VCYT) in Q3 2019, closing a stake of 8,776 shares — an estimated $250K sold.

Qtron Investments first reported a position in VCYT in Q1 2019 and held it in 2 quarters. The position peaked at $250K in Q2 2019. 187 funds tracked by Wall St. Rank hold VCYT as of Q3 2019.

  • Qtron Investments reported no remaining Veracyte position as of Q3 2019 after selling out during the quarter.
  • Qtron Investments sold 8,776 Veracyte shares in Q3 2019, an estimated $250K.
  • Qtron Investments first reported a position in Veracyte in Q1 2019 and held it in 2 quarters.
  • Qtron Investments's Veracyte position peaked at $250K in Q2 2019.
  • 187 funds tracked by Wall St. Rank held Veracyte as of Q3 2019.

Based on Qtron Investments's 13F filing for Q3 2019, filed 12 Nov 2019.